Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision/version identifier was updated from v3.5.2 to v3.5.3, indicating a non-content release update.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study content or page functionality.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check71 days agoChange DetectedResults posting details were added, including dates when results were first posted. The study documents were expanded with links to the protocol and informed consent forms, and the outcome measures were updated to specify RECIST-based endpoints and include multiple drug name synonyms.SummaryDifference5%

- Check86 days agoChange DetectedThe change is a minor version update (from v3.4.1 to v3.4.2) with no impact on study data, eligibility, or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.